EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Time to sputum culture conversion, treatment outcomes, and associated factors among rifampicin-resistant or multidrug-resistant tuberculosis patients in the Sidama region, Ethiopia: A retrospective follow-up study

Wolde Abreham Geda iD, Kebede Tefera Betru, Tarekegn Solomon, Solomon Daniel

PLOS One · 13.04.2026 · 21 (4) · e0327705

DOI: 10.1371/journal.pone.0327705 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS One, online erschienen am 13.04.2026. Verfasst von Wolde Abreham Geda und 3 weiteren Autor:innen. Beteiligte Einrichtung: Sidama Regional Public Health Institute, Hawassa, Sidama, Ethiopia. Hauptthemen laut MEDLINE: Rifampin, Tuberculosis, Multidrug-Resistant, Sputum, Antitubercular Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Time to sputum culture conversion is critical for follow-up treatment effectiveness in multidrug-resistant tuberculosis patients. However, the evidence regarding time to culture conversion, treatment outcomes, and the associated factors was sparse and inconsistent.

Objective

This study aimed to determine the time to culture conversion, treatment outcomes, and associated factors among rifampicin-resistant and multidrug-resistant tuberculosis cases in the Sidama region from April 1 to December 31, 2024.

Methods

We conducted a retrospective follow-up study of 346 patients who enrolled between January 2013 and June 2024. We collected data from patients’ medical records using a standardized form, entered the data, and analyzed it using Stata 16.1 software. We performed the analysis using the Kaplan-Meier model for time to culture conversion, Weibull distribution gamma frailty, and logistic regression models to assess factors associated with time to culture conversion and treatment outcomes, respectively. We considered an adjusted hazard or odds ratio with a 95% CI and a p-value < 0.05 to determine significance.

Results

Among the participants, 302 (87.3%) achieved culture conversion in a median time of 76 days (95% CI: 71–79 days). Patients with a history of previous loss to follow-up experienced an approximately fivefold delay in culture conversion (AHR = 0.2; 95% CI: 0.1–0.6; p = 0.001), while relapse cases had a twofold delay (AHR = 0.5; 95% CI: 0.2–0.9; p = 0.02) compared with new patients. The treatment success rate was 234/346 (67.6%). Female patients had higher odds of achieving a favorable treatment outcome (AOR = 1.8; 95% CI: 1.0–3.3; p = 0.04), whereas patients who experienced culture reversion had significantly lower odds of a favorable outcome (AOR = 0.05; 95% CI: 0–0.4; p = 0.001).

Conclusions

The majority of patients experienced culture conversion within three months. However, patients with a history of loss to follow-up and relapse experienced delayed culture conversion. These findings highlight the urgent need to improve patient adherence.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RifampinTuberculosis, Multidrug-ResistantSputumAntitubercular AgentsHumansFemaleRetrospective StudiesTreatment OutcomeMaleEthiopiaAdultFollow-Up StudiesMycobacterium tuberculosisMiddle AgedTime FactorsYoung Adult

Substanzen

RifampinAntitubercular Agents

Autor:innen und Institutionen

  • Sidama Regional Public Health Institute, Hawassa, Sidama, Ethiopia.
  • School of Public Health, College of Medicine and Health Sciences, Hawassa University, Hawassa, Sidama, Ethiopia.

ORCID-Profile: Wolde Abreham Geda

Zitieren

APA

Geda, W. A., Betru, K. T., Solomon, T., & Daniel, S. (2026). Time to sputum culture conversion, treatment outcomes, and associated factors among rifampicin-resistant or multidrug-resistant tuberculosis patients in the Sidama region, Ethiopia: A retrospective follow-up study. PLOS One, 21(4), e0327705. https://doi.org/10.1371/journal.pone.0327705

Vancouver

Geda WA, Betru KT, Solomon T, Daniel S. Time to sputum culture conversion, treatment outcomes, and associated factors among rifampicin-resistant or multidrug-resistant tuberculosis patients in the Sidama region, Ethiopia: A retrospective follow-up study. PLOS One. 2026;21(4):e0327705. doi:10.1371/journal.pone.0327705

BibTeX
@article{Geda2026,
  author = {Geda, Wolde Abreham and Betru, Kebede Tefera and Solomon, Tarekegn and Daniel, Solomon},
  title = {Time to sputum culture conversion, treatment outcomes, and associated factors among rifampicin-resistant or multidrug-resistant tuberculosis patients in the Sidama region, Ethiopia: A retrospective follow-up study},
  journal = {PLOS One},
  year = {2026},
  volume = {21},
  number = {4},
  pages = {e0327705},
  doi = {10.1371/journal.pone.0327705}
}
Kostenlos starten →